<ul>
<li>此次销售的总毛收益约为 26 亿瑞士法郎，其中 EQT 获得约 6.9 亿瑞士法郎</li>
</ul>
<p>, /PRNewswire/ -- 根据之前的公告，EQT VIII（&#34; <strong>EQT</strong>&#34;）的一个关联公司很高兴地宣布，已完成对 Galderma Group AG（SIX: GALD）（&#34; <strong>公司</strong>&#34;）的 2000 万股股票（&#34; <strong>股票</strong>&#34;）的配售，获得总毛收益约为 26 亿瑞士法郎，采用加速账簿建档程序（&#34; <strong>配售</strong>&#34;）。</p>
<p>作为配售的一部分，EQT 获得了约 6.9 亿瑞士法郎的毛收益。配售于 2025 年 10 月 30 日完成。花旗全球市场、高盛国际、杰富瑞、美国美林国际、摩根士丹利和瑞士银行担任配售的联合全球协调人和联合账簿管理人。</p>
<p><strong>联系方式</strong></p>
<p>EQT 新闻办公室，[email protected]</p>
<p><em><strong>重要通知</strong></em></p>
<p><em>本新闻稿不构成（i）对 Galderma Group AG 或其任何关联公司证券的出售要约或购买要约的征求，也不构成瑞士金融服务法意义上的招股说明书；（ii）在美国或其他地方的证券出售要约。除非在美国证券交易委员会注册或获得注册豁免，否则不得在美国提供或出售证券。本新闻稿中提到的任何证券在美国将不会进行公开发行。</em></p>
<p>此信息由 Cision 提供 http://news.cision.com</p>
<p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
<p>以下文件可供下载：</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>新闻稿，EQT VIII，Galderma，30102025</td>
</tr>
</tbody>
</table>
<p>来源：EQT</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx"/></p>

摩根士丹利

高盛

<p>EQT 已完成对 Galderma Group AG 的 2000 万股股票的出售，产生了约 26 亿瑞士法郎的总收益。EQT 从此次配售中获得了约 6.9 亿瑞士法郎，该交易于 2025 年 10 月 30 日完成。此次交易由花旗集团、高盛、杰富瑞、美林证券、摩根士丹利和瑞士银行作为联合全球协调人和账簿管理人进行促成。本公告不构成在美国或其他地方出售或招揽证券的要约</p>

<ul>
<li>The sale resulted in aggregate gross proceeds of c. CHF 2.6 billion, of which EQT received c. CHF 690 million</li>
</ul>
<div class="lb-trans"><ul>
<li>此次销售的总毛收益约为 26 亿瑞士法郎，其中 EQT 获得约 6.9 亿瑞士法郎</li>
</ul>
</div><p>, /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII (&#34; <strong>EQT</strong>&#34;) is pleased to announce the completion of the placement of 20 million shares in Galderma Group AG (SIX: GALD) (the &#34; <strong>Company</strong>&#34;) (the &#34; <strong>Shares</strong>&#34;) for aggregate gross proceeds of c. CHF 2.6 billion via an accelerated bookbuilding process (the &#34; <strong>Placement</strong>&#34;).</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 根据之前的公告，EQT VIII（&#34; <strong>EQT</strong>&#34;）的一个关联公司很高兴地宣布，已完成对 Galderma Group AG（SIX: GALD）（&#34; <strong>公司</strong>&#34;）的 2000 万股股票（&#34; <strong>股票</strong>&#34;）的配售，获得总毛收益约为 26 亿瑞士法郎，采用加速账簿建档程序（&#34; <strong>配售</strong>&#34;）。</p>
</div><p>As part of the Placement, EQT received gross proceeds of c. CHF 690 million. The Placement was completed on 30 October 2025. Citigroup Global Markets, Goldman Sachs International, Jefferies, Merrill Lynch International, Morgan Stanley and UBS acted as joint global coordinators and joint bookrunners for the Placement.</p>
<div class="lb-trans"><p>作为配售的一部分，EQT 获得了约 6.9 亿瑞士法郎的毛收益。配售于 2025 年 10 月 30 日完成。花旗全球市场、高盛国际、杰富瑞、美国美林国际、摩根士丹利和瑞士银行担任配售的联合全球协调人和联合账簿管理人。</p>
</div><p><strong>Contact</strong></p>
<div class="lb-trans"><p><strong>联系方式</strong></p>
</div><p>EQT Press Office, [email protected]</p>
<div class="lb-trans"><p>EQT 新闻办公室，[email protected]</p>
</div><p><em><strong>Important notice</strong></em></p>
<div class="lb-trans"><p><em><strong>重要通知</strong></em></p>
</div><p><em>This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States.</em></p>
<div class="lb-trans"><p><em>本新闻稿不构成（i）对 Galderma Group AG 或其任何关联公司证券的出售要约或购买要约的征求，也不构成瑞士金融服务法意义上的招股说明书；（ii）在美国或其他地方的证券出售要约。除非在美国证券交易委员会注册或获得注册豁免，否则不得在美国提供或出售证券。本新闻稿中提到的任何证券在美国将不会进行公开发行。</em></p>
</div><p>This information was brought to you by Cision http://news.cision.com</p>
<div class="lb-trans"><p>此信息由 Cision 提供 http://news.cision.com</p>
</div><p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
<div class="lb-trans"><p>https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4259423</p>
</div><p>The following files are available for download:</p>
<div class="lb-trans"><p>以下文件可供下载：</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>Press Release, EQT VIII, Galderma, 30102025</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>https://mb.cision.com/Main/87/4259423/3755401.pdf</td>
<td>新闻稿，EQT VIII，Galderma，30102025</td>
</tr>
</tbody>
</table>
</div><p>SOURCE EQT</p>
<div class="lb-trans"><p>来源：EQT</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDMwJk5ld3NJdGVtSWQ9SU8xMTYwMSZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMzAxMjUyUFJfTkVXU19VU1BSX19fX19JTzExNjAx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=IO11601&amp;Transmission_Id=202510301252PR_NEWS_USPR_____IO11601&amp;DateId=20251030"/></p>

EQT 完成了出售 Galderma Group AG 股份的交易